ARCHIVES

IMRT Less Toxic Than 3D-CRT In Localized Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Congress Plans to Accelerate Development of Drugs, Devices

December 19, 2014

DCT Board Approves Concept To Recomplete Data Management Contract

June 29, 1984

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

January 21, 2005

In Brief: David Nathan receives Lifetime Impact Award from Boston Children’s Hospital

November 7, 2014

Frederick RFP Held Up; NCI Probably Will Reject Any Further Delay

October 15, 1976

NCI’s New Divisional Structure In Place, Next Step Is Review Of Labs, Branches

October 13, 1995